Isoprenoid biosynthetic pathways as anti-infective drug targets

F Rohdich, A Bacher… - Biochemical Society …, 2005 - portlandpress.com
IPP (isopentenyl diphosphate) and DMAPP (dimethylallyl diphosphate) serve as the
universal precursors for the biosynthesis of isoprenoids. Besides the well-known …

Antimalarial drugs: current status and new developments

D Rathore, TF McCutchan, M Sullivan… - Expert opinion on …, 2005 - Taylor & Francis
Malaria continues to be a major threat in the developing world, with> 1 million clinical
episodes and 3000 deaths every day. In the last century, malaria claimed between 150 and …

The crystal structure of E. coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH …

A Mac Sweeney, R Lange, RPM Fernandes… - Journal of molecular …, 2005 - Elsevier
The key enzyme in the non-mevalonate pathway of isoprenoid biosynthesis, 1-deoxy-d-
xylulose 5-phosphate reductoisomerase (DXR) has been shown to be the target enzyme of …

[HTML][HTML] Reconstitution of an apicoplast-localised electron transfer pathway involved in the isoprenoid biosynthesis of Plasmodium falciparum

RC Röhrich, N Englert, K Troschke, A Reichenberg… - FEBS letters, 2005 - Elsevier
In the malaria parasite Plasmodium falciparum isoprenoid precursors are synthesised inside
a plastid-like organelle (apicoplast) by the mevalonate independent 1-deoxy-d-xylulose-5 …

Short-Course Regimens of Artesunate-Fosmidomycin in Treatment of Uncomplicated Plasmodium falciparum Malaria

S Borrmann, AA Adegnika, F Moussavou… - Antimicrobial agents …, 2005 - Am Soc Microbiol
Fosmidomycin is effective against malaria, but it needs to be given for≥ 4 days when used
alone. We conducted a study of 50 children with Plasmodium falciparum malaria to evaluate …

AFMoC enhances predictivity of 3D QSAR: a case study with DOXP-reductoisomerase

K Silber, P Heidler, T Kurz, G Klebe - Journal of medicinal …, 2005 - ACS Publications
We present structure− activity relationships for 43 inhibitors of 1-deoxyxylulose-5-phosphate
(DOXP)-reductoisomerase, derived from protein-based docking, ligand-based 3D QSAR …

The plastid-derived organelle ofprotozoan human parasites asa target of established and emerging drugs

J Wiesner, F Seeber - Expert Opinion on Therapeutic Targets, 2005 - Taylor & Francis
Human diseases like malaria, toxoplasmosis or cryptosporidiosis are caused by intracellular
protozoan parasites of the phylum Apicomplexa and are still a major health problem …

Parasite plastids: approaching the endgame

RJMI Wilson - Biological Reviews, 2005 - cambridge.org
Considerable work still needs to be done to understand more fully the basic processes
going on inside the non-photosynthetic plastid organelle of Plasmodium spp., the causative …

The Plastid of Plasmodium spp.: A Target for Inhibitors

S Sato, RJM Wilson - Malaria: Drugs, Disease and Post-genomic Biology, 2005 - Springer
Determined efforts are being made to explore the non-photosynthetic plastid organelle of
Plasmodium falciparum as a target for drug development. Certain antibiotics that block …

Fosmidomycin analogues as inhibitors of monoterpenoid indole alkaloid production in Catharanthus roseus cells

Z Mincheva, M Courtois, F Andreu, M Rideau… - Phytochemistry, 2005 - Elsevier
Substituted 3-[2-(diethoxyphosphoryl) propyl] oxazolo [4, 5-b] pyridine-2 (3H)-ones were
obtained by functionalization at 6-position with various substituents (aryl, vinyl, carbonyl …